SEC Form 4 · accession 0001803794-26-000003

ImageneBio, Inc. · IMA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Executive Officer · Director

Period of report

Aug 14, 2026

Accepted (ET)

Aug 17, 2026 · 5:00 pm EDT

Rule 10b5-1 plan

box not checked

Issuer CIK

0001835579

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Aug 14, 2026	A	254,800	$0.00	A	493,705	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (right to buy)^F2	$5.84	Aug 14, 2026	A	137,200	A	—	Aug 13, 2036	Common Stock	137,200	137,200	D
Employee Stock Option (Right to Buy)^F3	$5.84	Aug 14, 2026	A	250,000	A	—	Aug 13, 2036	Common Stock	250,000	250,000	D

F1Represents the number of shares of the Issuer's Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of Common Stock upon settlement. 25% of RSUs will vest and settle into Common Stock on April 14, 2027, and the remaing RSUs will vest in a series of 12 equal quarterly installments thereafter, subject to the Reporting Person's continuous service with the Issuer through each such vesting date.
F2The options vest over four years, with 25% of the shares vesting on April 14, 2027, and the remaining shares vesting in a series of 36 successive equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer through each such vesting date.
F3The options vest over four years in a series of 48 successive equal monthly installments commencing on May 14, 2026, subject to the Reporting Person's continuous service with the Issuer through each such vesting date.